Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the jetpack-backup domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/vgbdoo6u2d7y/public_html/mcmillanresearch.com/wp-includes/functions.php on line 6121
What in the World is a HIVICRON? - McMillan Research Limited
Select Page

What in the World is a HIVICRON?

May 1, 2024 | COVID-19, Immune Response, Public Health Policy, Research, Vaccination

Responsive Centered YouTube Video
Discussion on the highly virulent Omicron variant and upcoming events in vaccine research

  • Dr. Philip McMillan discusses the highly virulent Omicron variant and its link to mass vaccination • 0:21

  • The term ‘HIVICRON’ refers to the highly virulent Omicron variant, not related to HIV • 0:46

  • Dr. McMillan mentions a successful Kickstarter project for a book on nitric oxide • 1:52

  • Upcoming launch of the book ‘Homing Heroes’ on Amazon, with a focus on science storytelling • 2:01

  • Announcement of part two of the Advanced covid 360 course with research insights • 3:02

  • Opportunity to join the course pre-launch at a discounted price with over 30 modules planned • 3:36

  • Encouragement to subscribe and support ongoing research efforts • 3:59

Implications of emerging Omicron variants and challenges with current leadership in addressing the pandemic

  • Difficulty in predicting timelines for variant emergence post-vaccination • 4:17

  • Importance of understanding immune system response to variants • 5:06

  • Recognition of serious clinical implications of evolving variants • 5:31

  • Leadership reluctance to acknowledge mistakes hindering progress • 7:01

  • Historical reference to the need for accountable leadership in crises • 8:00

Discussion on the challenges posed by a highly virulent virus strain and the limitations of current strategies

  • Current vaccines may not effectively combat the highly virulent virus strain • 8:36

  • Vaccines may only reduce hospital stay, not mortality • 8:51

  • Concerns about the lack of effective strategies and acknowledgment of the severity of the situation • 9:00

  • Speculation on the emergence of a highly virulent H1N1 bird flu strain • 9:17

  • Discussion on the urgency of taking preventive measures to mitigate the potential consequences of the virus spread • 9:55

  • Explanation of how viral transmission slows down with vaccine breakthroughs but may lead to prolonged spread • 10:35

  • Emphasis on the need for innovative leadership to address the challenges posed by the virus strain • 11:10

Understanding the structure of Spike proteins and antibodies in relation to virus infectivity

  • Spike proteins on the virus surface bind to ACE2 receptors to enter cells and replicate • 12:44

  • Spike proteins have multiple binding points for ACE2, allowing for efficient cell entry • 13:00

  • Antibodies can block proper neutralization of the virus by binding to the Spike protein • 15:04

  • Presence of non-neutralizing antibodies may enhance virus infectivity by keeping Spike protein in open position • 15:46

  • Study on neutralizing antibodies and Omicron subvariant ba2.86 suggests potential for future highly virulent variants • 16:18

Impact of Omicron variant on highly vaccinated societies and immune response implications

  • Comparison of antibodies to Wuhan and BA286 strains, with immune system refocusing • 17:02

  • Warning of highly vaccinated societies being caught off guard by Omicron variant • 19:08

  • Discussion on immune escape, breakthrough infections, and cellular immune refocusing • 19:42

  • Prediction of severe phase in Covid-19 pandemic due to immune silencing • 20:33

  • Potential societal impacts of widespread illness in highly vaccinated regions • 21:01

Urgent call for action to address a potential health crisis caused by a new variant

  • Experts warn of a serious threat posed by a new variant called HIVICRON • 21:35

  • Leadership failing to conduct risk assessment and take necessary precautions • 21:45

  • Concerns raised about lack of proactive measures despite expert warnings • 22:00

  • Uncertainty about clinical implications and impact on different population groups • 23:06

  • Potential for severe outcomes like disseminated viral sepsis in a large patient cohort • 24:03

  • Urgent need to halt transmission and consider alternative treatments like horse paste • 25:04

  • Call for open-mindedness and willingness to explore unconventional solutions to save lives • 25:14

Implications of the highly virulent Omicron variant and the urgent need for action
  • Leaders must implement risk assessment and strategy for Omicron variant. • 25:51
  • Serious health concerns raised by Gert necessitate immediate attention. • 26:10
  • Urgent need for risk assessment, awareness, and preparation for potential crisis. • 27:02
  • Historical disbelief in past pandemics underscores the importance of being proactive now. • 27:18
  • Acknowledgment of potential severity of situation despite hopes for the contrary. • 27:49
  • Preparation and solution-seeking are imperative in the face of uncertainty. • 27:56